Cell population genetics and deep sequencing: A novel approach for drivers discovery in hepatocellular carcinoma

被引:0
|
作者
Alsinet, Clara [1 ]
Villanueva, Augusto [1 ]
Llovet, Josep M. [1 ,2 ,3 ]
机构
[1] Univ Barcelona, CIBERehd, Barcelona Clin Liver Canc Grp BCLC, Translat Res Lab & Liver Unit,IDIBAPS,Hosp Clin, Catalonia, Spain
[2] Tisch Canc Inst, Dept Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY USA
[3] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain
关键词
Liver cancer; Whole genome sequencing; Driver mutations discovery; MUTATIONS; GENOME;
D O I
10.1016/j.jhep.2011.11.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We present the analysis of the evolution of tumors in a case of hepatocellular carcinoma. This case is particularly informative about cancer growth dynamics and the underlying driving mutations. We sampled nine different sections from three tumors and seven more sections from the adjacent nontumor tissues. Selected sections were subjected to exon as well as whole-genome sequencing. Putative somatic mutations were then individually validated across all nine tumor and seven nontumor sections. Among the mutations validated, 24 were amino acid changes; in addition, 22 large indels/copy number variants (>1 Mb) were detected. These somatic mutations define four evolutionary lineages among tumor cells. Separate evolution and expansion of these lineages were recent and rapid, each apparently having only one lineage-specific protein-coding mutation. Hence, by using a cell-population genetic definition, this approach identified three coding changes (CCNG1, P62, and an indel/fusion gene) as tumor driver mutations. These three mutations, affecting cell cycle control and apoptosis, are functionally distinct from mutations that accumulated earlier, many of which are involved in inflammation/immunity or cell anchoring. These distinct functions of mutations at different stages may reflect the genetic interactions underlying tumor growth. (C) 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1198 / 1200
页数:3
相关论文
共 50 条
  • [1] Discovery and characterization of two novel drivers of hepatocellular carcinoma
    Feddersen, Charlotte R.
    Dupuy, Adam J.
    CANCER RESEARCH, 2016, 76
  • [2] Integrative approach to biomarker discovery by performing comparative analysis of two cancers Hepatocellular carcinoma and Endometrioid endometrial carcinoma using genetics and transcriptomics from RNA sequencing data
    Billaud, J.
    Tugendreich, S.
    Toburen, D.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 992 - 992
  • [3] Integrative approach to biomarker discovery by performing comparative analysis of two cancers, hepatocellular carcinoma and endometrioid endometrial carcinoma, using genetics and transcriptomics from RNA sequencing data
    Billaud, Jean-Noel
    Tugendreich, Stuart
    Toburen, Debra
    CANCER RESEARCH, 2017, 77
  • [4] Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing
    Yin, Dandan
    Zhou, Tao
    Xia, Xuyang
    Han, Chang
    Liu, Zhaoqian
    Li, Qiu
    Shu, Yang
    Xu, Heng
    MEDCOMM-ONCOLOGY, 2023, 2 (04):
  • [5] Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma
    Fan Yang
    Lin Jia
    Hong-chao Zhou
    Jing-nan Huang
    Meng-yun Hou
    Feng-ting Liu
    Nayana Prabhu
    Zhi-jie Li
    Chuan-bin Yang
    Chang Zou
    Pär Nordlund
    Ji-gang Wang
    Ling-yun Dai
    Acta Pharmacologica Sinica, 2024, 45 : 391 - 404
  • [6] Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma
    Yang, Fan
    Jia, Lin
    Zhou, Hong-chao
    Huang, Jing-nan
    Hou, Meng-yun
    Liu, Feng-ting
    Prabhu, Nayana
    Li, Zhi-jie
    Yang, Chuan-bin
    Zou, Chang
    Nordlund, Paer
    Wang, Ji-gang
    Dai, Ling-yun
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (02) : 391 - 404
  • [7] Population genetics meets single-cell sequencing
    Sumida, Tomokazu S.
    Hafler, David A.
    SCIENCE, 2022, 376 (6589) : 134 - 135
  • [8] Utilizing RNA aptamers for biomarker discovery in a novel cell culture system for hepatocellular carcinoma
    Naqvi, Ibtehaj A.
    White, Rebekah R.
    Moylan, Cynthia A.
    Diehl, Anna Mae
    Choi, Steve S.
    CANCER RESEARCH, 2014, 74 (19)
  • [9] DISCOVERY OF NOVEL KINASE INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
    Toffanin, S.
    Cabellos, L.
    Dong, H.
    Alsinet, C.
    Harrington, A.
    Cornella, H.
    Reddy, R. V.
    Reddy, P. M.
    Llovet, J. M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S446 - S447
  • [10] Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma
    Law, Priscilla T. -Y.
    Qin, Hao
    Ching, Arthur K. -K.
    Lai, Keng Po
    Co, Ngai Na
    He, Mian
    Lung, Raymond W. -M.
    Chan, Anthony W. -H.
    Chan, Ting-Fung
    Wong, Nathalie
    JOURNAL OF HEPATOLOGY, 2013, 58 (06) : 1165 - 1173